62 results
8-K
EX-99.1
BAX
Baxter International Inc.
2 May 24
Baxter Reports First-quarter 2024 Results
7:17am
, drug reimportation and disruptive technologies; global regulatory, trade and tax policies, including with respect to climate change and other
8-K
EX-99.1
5byu0e5 puan1jnx
8 Feb 24
Baxter Reports Fourth-quarter and Full-year 2023 Results
7:18am
8-K
EX-99.1
bqan98 khzlvx
2 Nov 23
Baxter Reports Third-quarter 2023 Results
7:18am
8-K
EX-99.1
0sf918zczqg cg2a
27 Jul 23
Baxter Reports Second-quarter 2023 Results
7:33am
8-K
EX-99.1
mjrwv4c6jmj
6 Jul 23
Regulation FD Disclosure
8:30am
SD
EX-1.01
925ewcmy9 o0
31 May 23
Conflict minerals disclosure
4:36pm
8-K
EX-2.1
con7bg9
9 May 23
Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to
8:42am
8-K
EX-99.1
9fu qt6k6ezk92
27 Apr 23
Baxter Reports First-quarter 2023 Results
7:18am
8-K
EX-99.1
pgh3zq9fagm6yuzp393
30 Sep 22
Entry into a Material Definitive Agreement
4:16pm
424B3
g4g12m36 kigeiw
12 May 22
Prospectus supplement
8:58am